Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways.

Taylor C, Fricker AD, Devi LA, Gomes I.

Cell Signal. 2005 May;17(5):549-57. Review.

PMID:
15683730
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].

Ströhle A.

Nervenarzt. 2003 Mar;74(3):279-91; quiz 292. German.

PMID:
12627245
[PubMed - indexed for MEDLINE]
3.

The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.

Masi G, Brovedani P.

CNS Drugs. 2011 Nov 1;25(11):913-31. doi: 10.2165/11595900-000000000-00000. Review.

PMID:
22054117
[PubMed - indexed for MEDLINE]
4.

Invited review: the evolution of antidepressant mechanisms.

Slattery DA, Hudson AL, Nutt DJ.

Fundam Clin Pharmacol. 2004 Feb;18(1):1-21. Review.

PMID:
14748749
[PubMed - indexed for MEDLINE]
5.

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.

Ressler KJ, Nemeroff CB.

Depress Anxiety. 2000;12 Suppl 1:2-19. Review.

PMID:
11098410
[PubMed - indexed for MEDLINE]
6.

Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice.

Thoeringer CK, Erhardt A, Sillaber I, Mueller MB, Ohl F, Holsboer F, Keck ME.

J Psychopharmacol. 2010 May;24(5):733-43. doi: 10.1177/0269881109103091. Epub 2009 Apr 3.

PMID:
19346277
[PubMed - indexed for MEDLINE]
7.

Vasopressin antagonists as anxiolytics and antidepressants: recent developments.

Simon NG, Guillon C, Fabio K, Heindel ND, Lu SF, Miller M, Ferris CF, Brownstein MJ, Garripa C, Koppel GA.

Recent Pat CNS Drug Discov. 2008 Jun;3(2):77-93. Review.

PMID:
18537767
[PubMed - indexed for MEDLINE]
8.

Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.

Millan MJ.

Neurotherapeutics. 2009 Jan;6(1):53-77. doi: 10.1016/j.nurt.2008.10.039. Review.

PMID:
19110199
[PubMed - indexed for MEDLINE]
9.

[The role of the hypothalamo-hypophyseal-adrenocortical system in the specific activity of antidepressive agents].

Arushanian EB, El'bek'ian KS.

Eksp Klin Farmakol. 1995 May-Jun;58(3):65-70. Review. Russian.

PMID:
7663305
[PubMed - indexed for MEDLINE]
10.

Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?

Barden N, Reul JM, Holsboer F.

Trends Neurosci. 1995 Jan;18(1):6-11. Review.

PMID:
7535490
[PubMed - indexed for MEDLINE]
11.

Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders.

Morilak DA, Frazer A.

Int J Neuropsychopharmacol. 2004 Jun;7(2):193-218. Epub 2004 Mar 5. Review.

PMID:
15003145
[PubMed - indexed for MEDLINE]
12.

Role of norepinephrine in depression.

Delgado PL, Moreno FA.

J Clin Psychiatry. 2000;61 Suppl 1:5-12. Review.

PMID:
10703757
[PubMed - indexed for MEDLINE]
13.

Antidepressants. Current concepts of mode of action.

Léonard BE.

Encephale. 1991 May-Jun;17 Spec No 1:127-31. Review.

PMID:
1677887
[PubMed - indexed for MEDLINE]
14.

New drug targets in the signaling pathways activated by antidepressants.

Páez-Pereda M.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):1010-6. Review.

PMID:
15946780
[PubMed - indexed for MEDLINE]
15.

[Mechanism of action of antidepressants and therapeutic perspectives].

Bourin M, David DJ, Jolliet P, Gardier A.

Therapie. 2002 Jul-Aug;57(4):385-96. Review. French.

PMID:
12422559
[PubMed - indexed for MEDLINE]
16.

New approaches to antidepressant drug discovery: beyond monoamines.

Berton O, Nestler EJ.

Nat Rev Neurosci. 2006 Feb;7(2):137-51. Review.

PMID:
16429123
[PubMed - indexed for MEDLINE]
17.

New insights into BDNF function in depression and anxiety.

Martinowich K, Manji H, Lu B.

Nat Neurosci. 2007 Sep;10(9):1089-93. Review.

PMID:
17726474
[PubMed - indexed for MEDLINE]
18.

[The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression].

Juruena MF, Cleare AJ, Pariante CM.

Rev Bras Psiquiatr. 2004 Sep;26(3):189-201. Epub 2004 Nov 17. Review. Portuguese. Erratum in: Rev Bras Psiquiatr. 2004 Dec;26(4):2 p following 300.

PMID:
15645065
[PubMed - indexed for MEDLINE]
Free Article
19.

Regulation of corticosteroid receptor gene expression in depression and antidepressant action.

Barden N.

J Psychiatry Neurosci. 1999 Jan;24(1):25-39.

PMID:
9987205
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Antidepressant-like activity of a Kampo (Japanese herbal) medicine, Koso-san (Xiang-Su-San), and its mode of action via the hypothalamic-pituitary-adrenal axis.

Ito N, Nagai T, Yabe T, Nunome S, Hanawa T, Yamada H.

Phytomedicine. 2006 Nov;13(9-10):658-67. Epub 2006 Mar 3.

PMID:
16516452
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk